DEUTSCHE BANK AG\
BankPosition in RVMD — Revolution Medicines, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in RVMD
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$45,294,964
+$42,728,881 QoQ
Shares Held
465,758
+1345.7% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 6.329467234057172.ToString("F0")%
Shared 0.ToString("F0")%
None 93.67053276594282.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. RVMD ranks #10 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in RVMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,294,964 | 465,758 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,566,083 | 32,217 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,498,462 | 32,087 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,108,077 | 30,119 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,422,314 | 153,346 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $7,758,732 | 177,383 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $5,096,704 | 112,386 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $3,552,395 | 91,533 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $3,121,829 | 96,861 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $3,379,506 | 117,835 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,467,067 | 53,001 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $1,247,165 | 46,623 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,301,959 | 106,277 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,061,573 | 86,548 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,626,346 | 82,472 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,630,629 | 83,665 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,206,817 | 86,508 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,271,918 | 90,263 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,458,181 | 89,356 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,459,181 | 108,985 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,657,184 | 79,712 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,332,875 | 33,667 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $730,834 | 21,001 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $234,754 | 7,436 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $107,468 | 4,905 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||